hAChE/Aβ1-42-IN-1 is a potent inhibitor of human acetylcholinesterase (hAChE) and Aβ1-42 aggregation; it exhibits acceptable relative safety in HepG2 cell lines, good blood-brain barrier (BBB) permeability, and a wide safety margin; it has potential for the research of Alzheimer's disease (AD).